If you've ever read the back of a fish oil bottle and felt like the math didn't add up, you're right. A typical softgel says "1,000 mg fish oil" on the front and, in smaller print, lists 180 mg EPA and 120 mg DHA on the back. That's 300 mg of the active fatty acids — roughly one-tenth of the dose used in the trials that actually moved inflammation markers.

This is the gap between marketing and pharmacology, and it's the reason so many people supplement omega-3s for a year and see no change on their labs.

What EPA and DHA actually do in the body

Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are long-chain omega-3 fatty acids. They get incorporated into cell membranes, where they shift the substrate pool away from arachidonic acid (pro-inflammatory eicosanoids) and toward resolvins and protectins — signaling molecules that actively turn inflammation off.

That mechanism is why we care, but it's also why dose matters. Membrane incorporation is dose-dependent and slow. You don't "top up" omega-3s the way you'd top up vitamin C. You change the composition of your cells over weeks to months.

How much EPA/DHA actually moves the labs — in plain English

Three biomarkers are worth tracking if you're supplementing with intent: triglycerides, hs-CRP, and the omega-3 index (the percentage of EPA+DHA in your red blood cell membranes).

Here's what the trial literature shows:

  • Triglycerides: The FDA-approved prescription omega-3 products (icosapent ethyl, omega-3-acid ethyl esters) are dosed at 4 grams per day of EPA or EPA+DHA. At that dose, REDUCE-IT and similar trials showed triglyceride reductions of 20-30% in hypertriglyceridemic patients. Below ~2 grams/day, the triglyceride effect is small and inconsistent.
  • hs-CRP: Meta-analyses (e.g., Li et al., Atherosclerosis 2014) show meaningful hs-CRP reductions at doses of 2-3 grams/day of combined EPA/DHA, sustained over 8-12 weeks. Lower doses produce noise.
  • Omega-3 index: The target range associated with lower cardiovascular risk is 8-12%. Most Americans sit at 4-5%. Reaching 8% typically requires 1.5-2 grams/day of combined EPA/DHA for 3-4 months, though the exact dose-response varies by baseline diet and genetics.

So the practical floor for inflammation work is roughly 2 grams/day of combined EPA+DHA, and the ceiling used safely in cardiovascular trials is 4 grams/day. That's 6-13 standard softgels — which is why most people unknowingly underdose.

If your fish oil bottle doesn't tell you the EPA and DHA milligrams separately, you can't dose it. Flip the bottle, do the math, or buy a concentrated product.

Why the standard softgel fails most people

A 1,000 mg fish oil softgel with 300 mg of EPA/DHA means the other 700 mg is other fatty acids and filler oils. To hit 2 grams of EPA/DHA from that product, you're taking ~7 softgels a day. To hit 4 grams, ~13.

Concentrated products (often labeled "triple-strength" or sold as ethyl esters or re-esterified triglycerides) deliver 600-900 mg of EPA/DHA per softgel. Two to four of those gets you into the therapeutic range.

The form matters less than the dose. Re-esterified triglyceride (rTG) form has slightly better absorption than ethyl ester (EE), but both work if taken with a meal containing fat. Taking omega-3s on an empty stomach can cut absorption by more than half.

{callout: The number that matters} For inflammation and triglyceride effects, target 2-4 grams of combined EPA+DHA per day — not 2-4 grams of "fish oil." Read the back label, add EPA and DHA together, and dose to that sum.

What a thorough workup would look at

If you're considering omega-3s as part of a cardiometabolic or inflammation strategy, the labs worth having before you start — and again at 12-16 weeks — typically include:

  • Lipid panel with triglycerides (fasting is ideal if triglycerides are the target)
  • hs-CRP (high-sensitivity C-reactive protein)
  • Omega-3 index, if available — this is the cleanest readout of whether your dose is actually landing
  • ApoB, if you're working on broader cardiovascular risk

A single hs-CRP can be elevated by a recent cold or workout, so interpret it in context. The omega-3 index is the most specific marker of whether your supplementation is working biochemically; the others tell you whether that biochemical change is translating into the downstream effects you care about.

Safety, bleeding risk, and the fish-burp problem

At doses up to 4 grams/day, omega-3s have a strong safety record. The two practical issues:

1. Atrial fibrillation signal at high doses. Trials like STRENGTH and REDUCE-IT showed a small increased incidence of atrial fibrillation at 4 g/day, particularly in patients with pre-existing cardiovascular disease. Worth discussing with a clinician if you have a history of arrhythmia. 2. Bleeding risk is theoretical at supplemental doses but real if you're on anticoagulants (warfarin, DOACs) or antiplatelets. Loop in your prescribing clinician before stacking.

GI side effects — fishy reflux, loose stools — are usually a formulation or storage problem. Refrigerate the bottle, take with the largest meal of the day, and switch to an rTG or enteric-coated product if it persists.

How long until labs move

Membrane turnover takes time. Realistic timelines:

  • Triglycerides: measurable change in 4-8 weeks at 3-4 g/day.
  • hs-CRP: 8-12 weeks at 2-3 g/day.
  • Omega-3 index: 12-16 weeks to reach steady state at a given dose.

If you re-test at 6 weeks and nothing has moved, the most likely explanations, in order, are: dose too low, taken without food, or not actually taken daily. Product quality is a distant fourth — most reputable brands meet label claim.

The practical protocol

For a generally healthy adult using omega-3s for inflammation and cardiometabolic support:

  • Pick a product that lists EPA and DHA separately on the supplement facts panel.
  • Target 2 grams/day of combined EPA+DHA as a starting dose for inflammation; 3-4 grams/day if triglycerides are elevated and you're working with a clinician.
  • Take with a fat-containing meal.
  • Re-check labs (triglycerides, hs-CRP, omega-3 index if available) at 12-16 weeks.
  • Adjust dose based on the omega-3 index if you have it; based on triglycerides and hs-CRP if you don't.

Omega-3s aren't a magic lever. They're one of the few supplements with enough trial data to dose like a drug, which means you can either dose them properly and measure the effect, or take a softgel a day and hope. The first approach is the only one the literature supports.

If you want the labs to confirm what your dose is actually doing, that's the part we can help with — real numbers, plain-English interpretation, and a protocol that's tuned to what your bloodwork shows rather than what the bottle promises.

Build your stack with intent.

Physician-formulated supplement protocols.

DirectCare AI clinicians curate supplement protocols matched to your actual bloodwork — not a generic multivitamin.

Browse supplements →

Editorial disclosure: This article is for informational purposes only and does not constitute medical advice. All treatments at DirectCare AI are prescribed by US-licensed clinicians based on individual medical evaluation. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Always consult a US-licensed clinician before starting or changing any therapy.